Clinical Trial Results TV

Main Menu

Series

Duke Clinical Medicine
SCAI TV

Categories


	Antithrombins: 21 submissions (showing 1 to 15)

| Page 1 | Page 2 |

CILON-T Late Breaking Trial
Dr. Hyo-Soo Kim

Dr. Tyrone Collins presents How to Establish a Stroke Center at Your Institution: Outreach, Research, & Education
Dr. Tyrone Collins

Dr. Bass reviews current clinical guidelines of oral antiplatelet therapy at the 2009 SCAI Fall Fellows conference
Dr. Ted Bass

In this wrap-up session, Dr. Robert Harrington and Dr. Duane Pinto discuss PLATO findings and the interpretation of rese
Dr. Robert Harrington, Dr. Duane Pinto

Dr. Neal S. Kleiman presents New Anti-Thrombotic Agents on the Horizon
Dr. Neal Kleiman, MD

Dr. Magnus E. Ohman presents Optimal Upstream Anti-Thrombin Therapy
Dr. Magnus Ohman

Drs. Harrington and Gibson discuss the BARI 2D trial, factor 10a inhibitors, and the need for more sensitive bleeding me
Dr. Robert Harrington, MD, Dr. C. Michael Gibson, MD

Dr. Sunil Rao presents Pharmacology and Mechanisms of Anti-Thrombin Therapy
Dr. Sunil Rao

Dr. Popma and Dr. Gibson discuss safety and efficacy with DES at TCT 08
Dr. Jeff Popma, Dr. C. Michael Gibson

Measurement of Clopidogrel Resistance by ADP-Inhibition
, Dr. Diana Gorog

Dr. Daniel Singer Discusses Anticoagulant Therapy for Atrial Fibrillation
Dr. Daniel Singer

Dr. Magnus Ohman discusses evidence-based medicine therapies for ACS
Dr. Magnus Ohman

Dr. Eric Peterson provides an update on the CRUSADE and ACTION Registries
Dr. Eric Peterson

The Efficacy and Safety of Fondaparinux in Elderly Patients With STEMI in OASIS 6 by Ron Peters, MD
Dr. Ron J.G. Peters

Dr. Jeffrey Anderson discusses the Couma-Gen Study at AHA 2007
Dr. Jeffrey Anderson